Literature DB >> 28246683

C S Betz1,2, A Leunig3.   

Abstract

In photodynamic therapy, neoplastic tissue is damaged and subsequently killed by the targeted illumination of previously photosensitized cells. This review is aimed at a comprehensive, but still easily understandable, presentation of all of the aspects of these methods relevant to ENT-doctors. Initially, an explanation of the clinically relevant difficulties in the therapy of (pre-)malignant lesions of the head and neck region, a historical synopsis of the development of this method and an illustration of the biophysical basics is given. The main part of the publication, however, revolves around the description of the current status of research and a presentation of internationally approved methods. At the end, a short overview of possible future developments in this field is given.

Keywords:  Actinic keratosis (AK); Head and neck cancer; Photodynamic therapy (PDT); Recurrent respiratory papillomatosis (RRP); Review

Year:  2004        PMID: 28246683     DOI: 10.1007/s00106-003-1029-1

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  126 in total

1.  Characterization of singlet oxygen.

Authors:  C S Foote; F C Shook; R B Abakerli
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

2.  Evidence for an important role of neutrophils in the efficacy of photodynamic therapy in vivo.

Authors:  W J de Vree; M C Essers; H S de Bruijn; W M Star; J F Koster; W Sluiter
Journal:  Cancer Res       Date:  1996-07-01       Impact factor: 12.701

3.  Photodynamic therapy in selected cases at the ENT Clinic, Innsbruck: case reports.

Authors:  J G Ofner; B Bartl; S König; W F Thumfart
Journal:  J Photochem Photobiol B       Date:  1996-11       Impact factor: 6.252

4.  Interstitial photodynamic therapy with rotating and reciprocating optical fibers.

Authors:  H Tanaka; K Hashimoto; I Yamada; K Masumoto; T Ohsawa; M Murai; T Hirano
Journal:  Cancer       Date:  2001-05-01       Impact factor: 6.860

5.  Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid.

Authors:  W E Grant; C Hopper; A J MacRobert; P M Speight; S G Bown
Journal:  Lancet       Date:  1993-07-17       Impact factor: 79.321

6.  Effect of photodynamic therapy on tumor necrosis factor production by murine macrophages.

Authors:  S Evans; W Matthews; R Perry; D Fraker; J Norton; H I Pass
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

7.  [Treatment of laryngeal papillomatosis with photodynamic laser therapy].

Authors:  J Feyh; E Kastenbauer
Journal:  Laryngorhinootologie       Date:  1992-04       Impact factor: 1.057

Review 8.  Photodynamic therapy and the treatment of head and neck cancers.

Authors:  M A Biel
Journal:  J Clin Laser Med Surg       Date:  1996-10

9.  Clinical effects of photodynamic therapy on recurrent laryngeal papillomas.

Authors:  A L Abramson; M J Shikowitz; V M Mullooly; B M Steinberg; C A Amella; H R Rothstein
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1992-01

10.  Laser phototherapy following HpD administration in superficial neoplastic lesions.

Authors:  G Bandieramonte; R Marchesini; E Melloni; C Andreoli; S di Pietro; P Spinelli; G Fava; F Zunino; H Emanuelli
Journal:  Tumori       Date:  1984-08-31
View more
  3 in total

Review 1.  [Photodynamic therapy using m-THPC (Foscan). Treatment of head and neck squamous cell carcinoma].

Authors:  R Naim
Journal:  HNO       Date:  2008-05       Impact factor: 1.284

2.  Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.

Authors:  Kai Johannes Lorenz; Heinz Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-17       Impact factor: 2.503

3.  [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.